NYSE - Nasdaq Real Time Price • USD
Charles River Laboratories International, Inc. (CRL)
As of 2:02 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 16 | 16 |
| Avg. Estimate | 2.07 | 2.65 | 11.02 | 12.43 |
| Low Estimate | 2 | 2.55 | 10.91 | 12.01 |
| High Estimate | 2.11 | 2.79 | 11.19 | 12.93 |
| Year Ago EPS | 2.78 | 2.69 | 10.67 | 11.02 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 15 | 15 |
| Avg. Estimate | 991.67M | 1.04B | 4.22B | 4.54B |
| Low Estimate | 979.4M | 1.02B | 4.2B | 4.41B |
| High Estimate | 1B | 1.06B | 4.26B | 4.71B |
| Year Ago Sales | 1.03B | 1.06B | 4.13B | 4.22B |
| Sales Growth (year/est) | -3.70% | -1.80% | 2.30% | 7.60% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 2.59 | 2.64 | 2.37 | 2.4 |
| EPS Actual | 2.78 | 2.69 | 2.72 | 2.46 |
| Difference | 0.19 | 0.05 | 0.35 | 0.06 |
| Surprise % | 7.30% | 1.90% | 14.80% | 2.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 2.07 | 2.65 | 11.02 | 12.43 |
| 7 Days Ago | 2.07 | 2.67 | 11.02 | 12.43 |
| 30 Days Ago | 2.14 | 2.69 | 11 | 12.41 |
| 60 Days Ago | 2.17 | 2.69 | 10.97 | 12.4 |
| 90 Days Ago | 2.51 | 2.67 | 10.81 | 12.26 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | 1 | -- | -- |
Growth Estimates
| CURRENCY IN USD | CRL | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -25.50% | -- | -- | 0.80% |
| Next Qtr. | -1.50% | -- | -- | 9.60% |
| Current Year | 3.30% | -- | -- | 4.50% |
| Next Year | 12.80% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 9.19% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 14.18% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Argus Research: Buy to Buy | 3/18/2024 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 2/15/2024 |
| Maintains | UBS: Buy to Buy | 2/15/2024 |
| Maintains | Citigroup: Neutral to Neutral | 2/15/2024 |
| Maintains | Baird: Outperform to Outperform | 2/15/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 2/15/2024 |
Related Tickers
ICLR ICON Public Limited Company
288.81
-1.03%
IQV IQVIA Holdings Inc.
226.12
-0.46%
MTD Mettler-Toledo International Inc.
1,192.66
+0.01%
IDXX IDEXX Laboratories, Inc.
474.38
-0.71%
DGX Quest Diagnostics Incorporated
128.34
+1.93%
WAT Waters Corporation
297.47
+1.10%
NOTV Inotiv, Inc.
4.4050
-6.28%
MEDP Medpace Holdings, Inc.
370.28
-1.08%
LH Laboratory Corporation of America Holdings
200.39
+0.47%
TMO Thermo Fisher Scientific Inc.
543.84
+0.43%